The DOI matches its Crossref record; 47 of the 47 references it cites were found in a registry or an index.
A new coronavirus associated with human respiratory disease in China
Open accessAbstract
Emerging infectious diseases, such as severe acute respiratory syndrome (SARS) and Zika virus disease, present a major threat to public health 1–3 . Despite intense research efforts, how, when and where new diseases appear are still a source of considerable uncertainty. A severe respiratory disease was recently reported in Wuhan, Hubei province, China. As of 25 January 2020, at least 1,975 cases had been reported since the first patient was hospitalized on 12 December 2019. Epidemiological investigations have suggested that the outbreak was associated with a seafood market in Wuhan. Here we study a single patient who was a worker at the market and who was admitted to the Central Hospital of Wuhan on 26 December 2019 while experiencing a severe respiratory syndrome that included fever, dizziness and a cough. Metagenomic RNA sequencing 4 of a sample of bronchoalveolar lavage fluid from the patient identified a new RNA virus strain from the family Coronaviridae , which is designated here ‘WH-Human 1’ coronavirus (and has also been referred to as ‘2019-nCoV’). Phylogenetic analysis of the complete viral genome (29,903 nucleotides) revealed that the virus was most closely related (89.1% nucleotide similarity) to a group of SARS-like coronaviruses (genus Betacoronavirus, subgenus Sarbecovirus) that had previously been found in bats in China 5 . This outbreak highlights the ongoing ability of viral spill-over from animals to cause severe disease in humans.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures












Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Alternatively, the ongoing COVID-19 global pandemic has the potential to dramatically affect mortality among the prevalent IBD population96.”
From The four epidemiological stages in the global evolution of inflammatory bowel disease (2021) · cites this paper as [96]
In the citing paper
“Both vaccines encode a stabilized ectodomain version of the S protein derived from the Wuhan-Hu-1 variant isolated in December 2019 (43)”
From mRNA vaccination boosts cross-variant neutralizing antibodies elicited by SARS-CoV-2 infection (2021) · cites this paper as [43]
In the citing paper
“Opportunistic oral bacteria, including Veillonella parvula, Capnocytophaga gingivalis, Leptotrichia buccalis, and Prevotella melaninogenia were overrepresented in bronchoalveolar lavage fluid of patients with COVID‐19, suggesting that the oral cavity may serve as a reservoir of bacteria implicated in coinfection with SARS‐CoV‐2 in COVID‐19.”
From The oral microbiome: Role of key organisms and complex networks in oral health and disease (2021) · cites this paper as [310]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Trimmomatic: a flexible trimmer for Illumina sequence data
Bolger, A. M., Lohse, M., & Usadel, B. (2014) · Bioinformatics · doi:10.1093/bioinformatics/btu170 · Cited by 65,548
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability
Katoh, K., & Standley, D. M. (2013) · Molecular Biology and Evolution · doi:10.1093/molbev/mst010 · Cited by 46,209
MUSCLE: multiple sequence alignment with high accuracy and high throughput
Edgar, R. C. (2004) · Nucleic Acids Research · doi:10.1093/nar/gkh340 · Cited by 44,662
Tamura, K., Peterson, D., Peterson, N., Stecher, G., Nei, M., & Kumar, S. (2011) · Molecular Biology and Evolution · doi:10.1093/molbev/msr121 · Cited by 40,207
A pneumonia outbreak associated with a new coronavirus of probable bat origin
Zhou, P., Yang, X.-L., Wang, X.-G., Hu, B., Zhang, L., Zhang, W., Si, H.-R., Zhu, Y., Li, B., Huang, C.-L., et al. (2020) · Nature · doi:10.1038/s41586-020-2012-7 · Cited by 21,969
Self-citationFull-length transcriptome assembly from RNA-Seq data without a reference genome
Grabherr, M. G., Haas, B. J., Yassour, M., Levin, J. Z., Thompson, D. A., Amit, I., Adiconis, X., Fan, L., Raychowdhury, R., Zeng, Q., et al. (2011) · Nature Biotechnology · doi:10.1038/nbt.1883 · Cited by 21,201
Guindon, S., Dufayard, J.-F., Lefort, V., Anisimova, M., Hordijk, W., & Gascuel, O. (2010) · Systematic Biology · doi:10.1093/sysbio/syq010 · Cited by 18,376
SWISS-MODEL: homology modelling of protein structures and complexes
Waterhouse, A. M., Bertoni, M., Bienert, S., Studer, G., Tauriello, G., Gumienny, R., Heer, F. T., de Beer, T., Rempfer, C., Bordoli, L., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gky427 · Cited by 13,248
Research works printed but not linked: 1
- Gorbalenya, A. E. Severe acute respiratory syndrome-related coronavirus — the species and its viruses, a statement of the Coronavirus Study Group. Preprint at bioRxiv https://doi.org/10.1101/2020.02.07.93786 (2020). · DOI
Cited by
Sorted by citations
Items 301–400 of 1,042
The COVID-19 Vaccine Race: Challenges and Opportunities in Vaccine Formulation
Wang, J., Peng, Y., Xu, H., Cui, Z., & Williams, R. O. (2020) · AAPS PharmSciTech · doi:10.1208/s12249-020-01744-7 · Cited by 335
The SARS-CoV-2 RNA–protein interactome in infected human cells
Schmidt, N., Lareau, C. A., Keshishian, H., Ganskih, S., Schneider, C., Hennig, T., Melanson, R., Werner, S., Wei, Y., Zimmer, M., et al. (2020) · Nature Microbiology · doi:10.1038/s41564-020-00846-z · Cited by 319
Pulmonary pathology of ARDS in COVID-19: A pathological review for clinicians
Batah, S. S., & Fabro, A. T. (2021) · Respiratory Medicine · doi:10.1016/j.rmed.2020.106239 · Cited by 319
Hand Sanitizers: A Review on Formulation Aspects, Adverse Effects, and Regulations
Jing, J. L. J., Yi, T. P., Bose, R. J., McCarthy, J. R., Tharmalingam, N., & Madheswaran, T. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17093326 · Cited by 356
Serology assays to manage COVID-19
Krammer, F., & Simon, V. R. (2020) · Science · doi:10.1126/science.abc1227 · Cited by 323
Rockett, R. J., Arnott, A., Lam, C., Sadsad, R., Timms, V. J., Gray, K.-A., Eden, J., Chang, S. L., Gall, M. L., Draper, J. L., et al. (2020) · Nature Medicine · doi:10.1038/s41591-020-1000-7 · Cited by 341
Self-citationAnka, A. U., Tahir, M. I., Abubakar, S. D., Alsabbagh, M. Y., Zian, Z., Hamedifar, H., Sabzevari, A., & Azizi, G. (2020) · Scandinavian Journal of Immunology · doi:10.1111/sji.12998 · Cited by 365
Incidence and Severity of COVID-19 in HIV-Positive Persons Receiving Antiretroviral Therapy
del Amo, J., Polo, R., Moreno, S., Díaz, A., Martínez, E., Arribas, J. R., Jarrín, I., & Hernán, M. Á. (2020) · Annals of Internal Medicine · doi:10.7326/m20-3689 · Cited by 324
SARS-CoV-2 proteome microarray for global profiling of COVID-19 specific IgG and IgM responses
Jiang, H.-W., Li, Y., Zhang, H.-N., Wang, W., Yang, X., Qi, H., Li, H., Men, D., Zhou, J., & Tao, S.-C. (2020) · Nature Communications · doi:10.1038/s41467-020-17488-8 · Cited by 329
Self-citationAtri, D. S., Siddiqi, H. K., Lang, J. P., Nauffal, V., Morrow, D. A., & Bohula, E. A. (2020) · JACC Basic to Translational Science · doi:10.1016/j.jacbts.2020.04.002 · Cited by 337
Nanozyme chemiluminescence paper test for rapid and sensitive detection of SARS-CoV-2 antigen
Liu, D., Ju, C., Han, C., Shi, R., Chen, X., Duan, D., Yan, J., & Yan, X. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112817 · Cited by 329
Fu, Z., Huang, B., Tang, J., Liu, S., Liu, M., Ye, Y., Liu, Z., Xiong, Y., Zhu, W., Cao, D., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20718-8 · Cited by 346
Coast-to-Coast Spread of SARS-CoV-2 during the Early Epidemic in the United States
Fauver, J. R., Petrone, M. E., Hodcroft, E. B., Shioda, K., Ehrlich, H. Y., Watts, A., Vogels, C. B. F., Brito, A. F., Alpert, T., Muyombwe, A., et al. (2020) · Cell · doi:10.1016/j.cell.2020.04.021 · Cited by 319
Baek, Y. H., Um, J., Antigua, K. J. C., Park, J. H., Kim, Y., Oh, S., Kim, Y., Choi, W.-S., Kim, S. G., Jeong, J. H., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1756698 · Cited by 319
Structures of the SARS‐CoV‐2 nucleocapsid and their perspectives for drug design
Peng, Y., Du, N., Lei, Y., Dorje, S., Qi, J., Luo, T., Gao, G. F., & Song, H. (2020) · The EMBO Journal · doi:10.15252/embj.2020105938 · Cited by 320
Lipid droplets fuel SARS-CoV-2 replication and production of inflammatory mediators
Dias, S. D. S. G., Soares, V. C., Ferreira, A. C., Sacramento, C. Q., Rodrigues, N. F., Temerozo, J. R., Teixeira, L., da Silva, M. A. N., Barreto, E. A., Mattos, M., et al. (2020) · PLoS Pathogens · doi:10.1371/journal.ppat.1009127 · Cited by 336
iSCAN: An RT-LAMP-coupled CRISPR-Cas12 module for rapid, sensitive detection of SARS-CoV-2
Ali, Z., Aman, R. A., Mahas, A., Rao, G. S., Tehseen, M., Maršić, T., Salunke, R. P., Subudhi, A. K., Hala, S. M., Hamdan, S. M., et al. (2020) · Virus Research · doi:10.1016/j.virusres.2020.198129 · Cited by 318
Alexandersen, S., Chamings, A., & Bhatta, T. R. (2020) · Nature Communications · doi:10.1038/s41467-020-19883-7 · Cited by 305
Grzelak, L., Temmam, S., Planchais, C., Demeret, C., Tondeur, L., Huon, C., Guivel-Benhassine, F., Staropoli, I., Chazal, M., Dufloo, J., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.abc3103 · Cited by 310
SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
Wibmer, C. K., Ayres, F., Hermanus, T., Madzivhandila, M., Kgagudi, P., Oosthuysen, B., Lambson, B. E., de Oliveira, T., Vermeulen, M., van der Berg, K., et al. (2021) · doi:10.1101/2021.01.18.427166
Kirtipal, N., Bharadwaj, S., & Kang, S. G. (2020) · Infection Genetics and Evolution · doi:10.1016/j.meegid.2020.104502 · Cited by 339
SalivaDirect: A simplified and flexible platform to enhance SARS-CoV-2 testing capacity
Vogels, C. B. F., Watkins, A. E., Harden, C. A., Brackney, D. E., Shafer, J., Wang, J., Caraballo, C., Kalinich, C. C., Ott, I. M., Fauver, J. R., et al. (2020) · Med · doi:10.1016/j.medj.2020.12.010 · Cited by 306
Caly, L., Druce, J. D., Roberts, J., Bond, K. A., Tran, T., Kostecki, R., Yoga, Y., Naughton, W., Taiaroa, G., Seemann, T., et al. (2020) · The Medical Journal of Australia · doi:10.5694/mja2.50569 · Cited by 305
Genotyping coronavirus SARS-CoV-2: methods and implications
Yin, C. (2020) · Genomics · doi:10.1016/j.ygeno.2020.04.016 · Cited by 302
Calabrese, F., Pezzuto, F., Fortarezza, F., Hofman, P. M., Kern, I., Panizo, Á., von der Thüsen, J. H., Timofeev, S., Gorkiewicz, G., & Lunardi, F. (2020) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/s00428-020-02886-6 · Cited by 311
Fan, H., Wang, L.-Q., Liu, W.-L., An, X.-P., Liu, Z.-D., He, X.-Q., Song, L.-H., & Tong, Y.-G. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000797 · Cited by 311
Li, J., Yang, A., Dou, K., Wang, L., Zhang, M., & Lin, X.-Q. (2020) · BMC Public Health · doi:10.1186/s12889-020-09695-1 · Cited by 321
COVID-19 and immunomodulation in IBD
Neurath, M. F. (2020) · Gut · doi:10.1136/gutjnl-2020-321269 · Cited by 305
Zheng, Y., Zhuang, M.-W., Han, L., Zhang, J., Nan, M.-L., Zhan, P., Kang, D., Liu, X., Gao, C., & Wang, P.-H. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-00438-7 · Cited by 302
SARS-CoV-2 Mpro inhibitors and activity-based probes for patient-sample imaging
Rut, W., Groborz, K. M., Zhang, L., Sun, X., Żmudziński, M., Pawlik, B., Wang, X., Jochmans, D., Neyts, J. H., Mlynarski, W. M., et al. (2020) · Nature Chemical Biology · doi:10.1038/s41589-020-00689-z · Cited by 303
Ghosh, R., Chakraborty, A., Biswas, A., & Chowdhuri, S. (2020) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2020.1779818 · Cited by 305
Overview of lethal human coronaviruses
Chen, B., Tian, E.-K., He, B., Tian, L., Han, R., Wang, S., Xiang, Q., Zhang, S., Arnaout, T. E., & Cheng, W. (2020) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-020-0190-2 · Cited by 309
Drug Development and Medicinal Chemistry Efforts toward SARS‐Coronavirus and Covid‐19 Therapeutics
Ghosh, A. K., Brindisi, M., Shahabi, D., Chapman, M. E., & Mesecar, A. D. (2020) · ChemMedChem · doi:10.1002/cmdc.202000223 · Cited by 306
Disseminated intravascular coagulation in patients with 2019‐nCoV pneumonia
Lillicrap, D. (2020) · Journal of Thrombosis and Haemostasis · doi:10.1111/jth.14781 · Cited by 299
García, R. A., Hoehn, D., Laso, J., Margallo, M., Ruiz‐Salmón, I., Cristóbal, J., Kahhat, R. F., Villanueva-Rey, P., Bala, A., Batlle-Bayer, L., et al. (2020) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2020.140524 · Cited by 298
Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost
Muecksch, F., Wang, Z., Cho, A., Gaebler, C., Ben Tanfous, T., DaSilva, J., Bednarski, E., Ramos, V., Zong, S., Johnson, B., et al. (2022) · Nature · doi:10.1038/s41586-022-04778-y · Cited by 297
Lectins enhance SARS-CoV-2 infection and influence neutralizing antibodies
Lempp, F. A., Soriaga, L. B., Montiel-Ruiz, M., Benigni, F., Noack, J., Park, Y., Bianchi, S., Walls, A. C., Bowen, J. E., Zhou, J., et al. (2021) · Nature · doi:10.1038/s41586-021-03925-1 · Cited by 305
Zhang, C., Zheng, W. H., Huang, X., Bell, E. W., Zhou, X., & Zhang, Y. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00129 · Cited by 301
Self-citationThe Role and Therapeutic Potential of NF-kappa-B Pathway in Severe COVID-19 Patients
Hariharan, A., Hakeem, A. R., Radhakrishnan, S., Reddy, M. S., & Rela, M. (2020) · Inflammopharmacology · doi:10.1007/s10787-020-00773-9 · Cited by 300
Type I and III interferon responses in SARS-CoV-2 infection
Kim, Y., & Shin, E. (2021) · Experimental & Molecular Medicine · doi:10.1038/s12276-021-00592-0 · Cited by 304
Genomic characterization and epidemiology of an emerging SARS-CoV-2 variant in Delhi, India
Dhar, M. S., Marwal, R., Radhakrishnan, V. S., Ponnusamy, K., Jolly, B., Bhoyar, R. C., Sardana, V., Naushin, S., Rophina, M., Mellan, T. A., et al. (2021) · Science · doi:10.1126/science.abj9932 · Cited by 300
Genomic characterization and Epidemiology of an emerging SARS-CoV-2 variant in Delhi, India
Dhar, M. S., Marwal, R., Radhakrishnan, V., Ponnusamy, K., Jolly, B., Bhoyar, R. C., Sardana, V., Naushin, S., Rophina, M., Mellan, T. A., et al. (2021) · doi:10.1101/2021.06.02.21258076 · Cited by 296
A Review on Deep Learning Techniques for the Diagnosis of Novel Coronavirus (COVID-19)
Islam, M. M., Karray, F. O., Alhajj, R., & Zeng, J. (2021) · IEEE Access · doi:10.1109/access.2021.3058537 · Cited by 299
Structural biology of SARS-CoV-2: open the door for novel therapies
Yan, W., Zheng, Y., Zeng, X., He, B., & Cheng, W. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-00884-5 · Cited by 314
Attenuated SARS-CoV-2 variants with deletions at the S1/S2 junction
Lau, S.-Y., Wang, P., Mok, B. W.-Y., Zhang, J., Chu, H., Lee, A. C.-Y., Deng, S., Chen, P., Chan, K., Song, W., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1756700 · Cited by 288
Dietary therapy and herbal medicine for COVID-19 prevention: A review and perspective
Panyod, S., Ho, C., & Sheen, L. (2020) · Journal of Traditional and Complementary Medicine · doi:10.1016/j.jtcme.2020.05.004 · Cited by 296
Critical Determinants of Cytokine Storm and Type I Interferon Response in COVID-19 Pathogenesis
Ramasamy, S., & Subbian, S. (2021) · Clinical Microbiology Reviews · doi:10.1128/cmr.00299-20 · Cited by 307
Evidence for a mouse origin of the SARS-CoV-2 Omicron variant
Wei, C., Shan, K.-J., Wang, W., Zhang, S., Huan, Q., & Qian, W. (2021) · Journal of genetics and genomics/Journal of Genetics and Genomics · doi:10.1016/j.jgg.2021.12.003 · Cited by 278
Self-citationGlobal landscape of SARS-CoV-2 genomic surveillance and data sharing
Chen, Z., Azman, A. S., Chen, X., Zou, J., Tian, Y., Sun, R., Xu, X., Wu, Y., Lu, W., Ge, S., et al. (2022) · Nature Genetics · doi:10.1038/s41588-022-01033-y · Cited by 303
Antibody Tests in Detecting SARS-CoV-2 Infection: A Meta-Analysis
Kontou, P. I., Braliou, G. G., Dimou, N. L., Nikolopoulos, G. K., & Bagos, P. G. (2020) · Diagnostics · doi:10.3390/diagnostics10050319 · Cited by 287
Pharmaco-Immunomodulatory Therapy in COVID-19
Rizk, J. G., Kalantar‐Zadeh, K., Mehra, M. R., Lavie, C. J., Rizk, Y., & Forthal, D. N. (2020) · Drugs · doi:10.1007/s40265-020-01367-z · Cited by 298
Thomas, T. A., Stefanoni, D., Dzieciątkowska, M., Issaian, A., Nemkov, T. G., Hill, R. C., Francis, R. O., Hudson, K. E., Buehler, P. W., Zimring, J. C., et al. (2020) · Journal of Proteome Research · doi:10.1021/acs.jproteome.0c00606 · Cited by 291
Tan, T. K., Rijal, P., Rahikainen, R., Keeble, A. H., Schimanski, L. M., Hussain, S., Harvey, R., Hayes, J. W. P., Edwards, J. C., McLean, R. K., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20654-7 · Cited by 287
Dong, E., Ratcliff, J., Goyea, T. D., Katz, A., Lau, R., Ng, T. K., Garcia, B., Bolt, E., Prata, S., Zhang, D., et al. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(22)00434-0 · Cited by 301
Current epidemiological and clinical features of COVID-19; a global perspective from China
Tu, H., Tu, S., Gao, S., Shao, A., & Sheng, J. (2020) · Journal of Infection · doi:10.1016/j.jinf.2020.04.011 · Cited by 293
SARS-CoV-2-Specific Immune Response and the Pathogenesis of COVID-19
Gusev, E., Sarapultsev, A., Владимировна, С. Л., & Черешнев, В. А. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031716 · Cited by 326
Three-dimensional human alveolar stem cell culture models reveal infection response to SARS-CoV-2
Youk, J., Kim, T., Evans, K. V., Jeong, Y.-I., Hur, Y., Hong, S. P., Kim, J. H., Yi, K., Kim, S. Y., Na, K. J., et al. (2020) · Cell Stem Cell · doi:10.1016/j.stem.2020.10.004 · Cited by 266
“Currently, coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is spreading globally (Wu et al., 2020), and more than 35.8 million confirmed cases and 1.05 million deaths have been reported worldwide as of October 7, 2020.”
BackgroundInfluentialSimmonds, P. (2020) · mSphere · doi:10.1128/msphere.00408-20 · Cited by 245
Ogando, N. S., Zevenhoven-Dobbe, J. C., van der Meer, Y., Bredenbeek, P. J., Posthuma, C. C., & Snijder, E. J. (2020) · Journal of Virology · doi:10.1128/jvi.01246-20 · Cited by 284
Impact of COVID-19 outbreaks and interventions on influenza in China and the United States
Feng, L., Zhang, T., Wang, Q., Xie, Y., Peng, Z., Zheng, J., Qin, Y., Zhang, M., Lai, S., Wang, D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-23440-1 · Cited by 277
Self-citationRNA genome conservation and secondary structure in SARS-CoV-2 and SARS-related viruses: a first look
Rangan, R., Zheludev, I. N., Hagey, R. J., Pham, E. A., Wayment-Steele, H. K., Glenn, J. S., & Das, R. (2020) · RNA · doi:10.1261/rna.076141.120 · Cited by 278
Funari, R., Chu, K.-Y., & Shen, A. Q. (2020) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2020.112578 · Cited by 283
The coronavirus proofreading exoribonuclease mediates extensive viral recombination
Gribble, J., Pruijssers, A. J. P., Agostini, M. L., Anderson-Daniels, J., Chappell, J. D., Lu, X., Stevens, L. J., Routh, A. L., & Denison, M. R. (2021) · PLoS Pathogens · doi:10.1371/journal.ppat.1009226 · Cited by 269
SARS-CoV-2 mRNA Vaccines: Immunological Mechanism and Beyond
Bettini, E., & Locci, M. (2021) · Vaccines · doi:10.3390/vaccines9020147 · Cited by 292
COVID-19: animals, veterinary and zoonotic links
Tiwari, R., Dhama, K., Sharun, K., Yatoo, M. I., Malik, Y. S., Singh, R. K., Michalak, I., Sah, R., Bonilla‐Aldana, D. K., & Rodriguez-Morales, A. J. (2020) · Veterinary Quarterly · doi:10.1080/01652176.2020.1766725 · Cited by 288
Appelberg, S., Gupta, S., Akusjärvi, S. S., Ambikan, A. T., Mikaeloff, F., Saccon, E., Végvári, Á., Benfeitas, R., Sperk, M., Ståhlberg, M., et al. (2020) · Emerging Microbes & Infections · doi:10.1080/22221751.2020.1799723 · Cited by 276
COVID-19 vaccine: A recent update in pipeline vaccines, their design and development strategies
Rawat, K., Kumari, P., & Saha, L. (2020) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2020.173751 · Cited by 282
The outbreak of SARS-CoV-2 pneumonia calls for viral vaccines
Shang, W., Yang, Y., Rao, Y., & Rao, X. (2020) · npj Vaccines · doi:10.1038/s41541-020-0170-0 · Cited by 275
Anti-SARS-CoV-2 receptor-binding domain antibody evolution after mRNA vaccination
Cho, A., Muecksch, F., Schaefer-Babajew, D. J., Wang, Z., Finkin, S., Gaebler, C., Ramos, V., Cipolla, M., Mendoza, P., Agudelo, M., et al. (2021) · Nature · doi:10.1038/s41586-021-04060-7 · Cited by 263
The Effect of Large-Scale Anti-Contagion Policies on the COVID-19 PandemicPreprint
Hsiang, S., Allen, D., Annan-Phan, S., Bell, K., Bolliger, I. W., Chong, T., Druckenmiller, H., Huang, L. Y., Hultgren, A., Krasovich, E., et al. (2020) · medRxiv · doi:10.1101/2020.03.22.20040642 · Cited by 275
The value of clinical parameters in predicting the severity of COVID‐19
Shang, W., Dong, J., Ren, Y., Tian, M., Li, W., Hu, J., & Li, Y. (2020) · Journal of Medical Virology · doi:10.1002/jmv.26031 · Cited by 279
COVID-19, Renin-Angiotensin System and Endothelial Dysfunction
Amraei, R., & Rahimi, N. (2020) · Cells · doi:10.3390/cells9071652 · Cited by 281
An in silico deep learning approach to multi-epitope vaccine design: a SARS-CoV-2 case study
Yang, Z., Bogdan, P., & Nazarian, S. (2021) · Scientific Reports · doi:10.1038/s41598-021-81749-9 · Cited by 271
SARS-CoV-2: from its discovery to genome structure, transcription, and replication
Brant, A. C., Tian, W., Majerčiak, V., Yang, W., & Zheng, Z. (2021) · Cell & Bioscience · doi:10.1186/s13578-021-00643-z · Cited by 299
Analytical validity of nanopore sequencing for rapid SARS-CoV-2 genome analysis
Bull, R. A., Adikari, T. N., Ferguson, J. M., Hammond, J. W., Stevanovski, I., Beukers, A. G., Naing, Z., Yeang, M., Verich, A., Gamaarachchi, H., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-20075-6 · Cited by 275
Nucleic Acid Tests for Clinical Translation
Li, M., Yin, F., Song, L., Mao, X., Li, F., Fan, C., Zuo, X., & Xia, Q. (2021) · Chemical Reviews · doi:10.1021/acs.chemrev.1c00241 · Cited by 274
Monocytes and Macrophages in COVID-19
Knoll, R., Schultze, J. L., & Schulte-Schrepping, J. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.720109 · Cited by 279
ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection
Hachim, A., Kavian, N., Cohen, C. A., Chin, A. W. H., Chu, D. K. W., Mok, C. K. P., Tsang, O. T., Yeung, Y. C., Perera, R. A. P. M., Poon, L. L. M., et al. (2020) · Nature Immunology · doi:10.1038/s41590-020-0773-7 · Cited by 270
Pang, B., Xu, J., Liu, Y., Peng, H., Feng, W., Cao, Y., Wu, J., Xiao, H., Pabbaraju, K., Tipples, G. A., et al. (2020) · Analytical Chemistry · doi:10.1021/acs.analchem.0c04047 · Cited by 269
Self-citationDivergent SARS-CoV-2 variant emerges in white-tailed deer with deer-to-human transmission
Pickering, B., Lung, O., Maguire, F., Kruczkiewicz, P., Kotwa, J. D., Buchanan, T., Gagnier, M., Guthrie, J. L., Jardine, C. M., Marchand‐Austin, A., et al. (2022) · Nature Microbiology · doi:10.1038/s41564-022-01268-9 · Cited by 266
Identification of Human Single-Domain Antibodies against SARS-CoV-2
Wu, Y., Li, C., Xia, S., Tian, X., Kong, Y., Wang, Z., Gu, C., Zhang, R., Tu, C., Xie, Y., et al. (2020) · Cell Host & Microbe · doi:10.1016/j.chom.2020.04.023 · Cited by 264
ACE2 localizes to the respiratory cilia and is not increased by ACE inhibitors or ARBs
Lee, I. T., Nakayama, T., Wu, C.-T., Goltsev, Y., Jiang, S., Gall, P. A., Liao, S. C., Shih, L., Schürch, C. M., McIlwain, D. R., et al. (2020) · Nature Communications · doi:10.1038/s41467-020-19145-6 · Cited by 261
Mhatre, S., Srivastava, T., Naik, S. V., & Patravale, V. B. (2020) · Phytomedicine · doi:10.1016/j.phymed.2020.153286 · Cited by 265
Azuma, K., Yanagi, U., Kagi, N., Kim, H., OGATA, M., & Hayashi, M. (2020) · Environmental Health and Preventive Medicine · doi:10.1186/s12199-020-00904-2 · Cited by 276
Two Detailed Plaque Assay Protocols for the Quantification of Infectious SARS‐CoV‐2
Mendoza, E. J., Manguiat, K., Wood, H., & DREBOT, M. A. (2020) · Current Protocols in Microbiology · doi:10.1002/cpmc.105 · Cited by 260
Susceptibility of White-Tailed Deer (Odocoileus virginianus) to SARS-CoV-2
Palmer, M. V., Martins, M., Falkenberg, S. M., Buckley, A., Caserta, L. C., Mitchell, P. K., Cassmann, E. D., Rollins, A., Zylich, N. C., Renshaw, R. W., et al. (2021) · Journal of Virology · doi:10.1128/jvi.00083-21 · Cited by 257
Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives
Tandon, R., Sharp, J. S., Zhang, F., Pomin, V. H., Ashpole, N. M., Mitra, D., McCandless, M. G., Jin, W., Liu, H., Sharma, P. C., et al. (2020) · Journal of Virology · doi:10.1128/jvi.01987-20 · Cited by 263
Billah, M. A., Miah, M. M., & Khan, M. N. (2020) · PLOS ONE · doi:10.1371/journal.pone.0242128 · Cited by 260
Glycoconjugates: Synthesis, Functional Studies, and Therapeutic Developments
Shivatare, S. S., Shivatare, V. S., & Wong, C. (2022) · Chemical Reviews · doi:10.1021/acs.chemrev.1c01032 · Cited by 266
Trends and strategies to combat viral infections: A review on FDA approved antiviral drugs
Tompa, D. R., Immanuel, A., Srikanth, S., & Saraboji, K. (2021) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2021.01.076 · Cited by 278
Mody, V. V., Ho, J., Wills, S., Mawri, A., Lawson, L., Ebert, M. C. C. J. C., Fortin, G. M., Rayalam, S., & Taval, S. (2021) · Communications Biology · doi:10.1038/s42003-020-01577-x · Cited by 272
High‐Throughput Metagenomics for Identification of Pathogens in the Clinical Settings
Li, N., Cai, Q., Miao, Q., Song, Z., Fang, Y., & Hu, B. (2020) · Small Methods · doi:10.1002/smtd.202000792 · Cited by 265
Self-citationStructure, mechanism and crystallographic fragment screening of the SARS-CoV-2 NSP13 helicase
Newman, J. A., Douangamath, A., Yazdani, S., Yosaatmadja, Y., Aimon, A., Brandão-Neto, J., Dunnett, L. E., Gorrie-Stone, T. J., Skyner, R., Fearon, D., et al. (2021) · Nature Communications · doi:10.1038/s41467-021-25166-6 · Cited by 262
Ahmad, A., BANAT, F. A., AlSafar, H. S., & Hasan, S. W. (2021) · The Science of The Total Environment · doi:10.1016/j.scitotenv.2021.150585 · Cited by 264
Haveri, A., Smura, T., Kuivanen, S. H., Österlund, P., Hepojoki, J., Ikonen, N., Pitkäpaasi, M., Blomqvist, S., Rönkkö, E., Kantele, A., et al. (2020) · Eurosurveillance · doi:10.2807/1560-7917.es.2020.25.11.2000266 · Cited by 255
COVID-19: Virology, biology and novel laboratory diagnosis
Mohamadian, M., Chiti, H., Shoghli, A., Biglari, S., Parsamanesh, N., & Esmaeilzadeh, A. (2021) · The Journal of Gene Medicine · doi:10.1002/jgm.3303 · Cited by 371
Sallam, M., Dababseh, D., Yaseen, A. I. B., Al-Haidar, A., Ababneh, N. A., Bakri, F. G., & Mahafzah, A. M. (2020) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph17144915 · Cited by 259
Augustine, R., Hasan, A., Das, S., Ahmed, R., Mori, Y., Notomi, T., Kevadiya, B. D., & Thakor, A. S. (2020) · Biology · doi:10.3390/biology9080182 · Cited by 254
Puzzling Haze Events in China During the Coronavirus (COVID‐19) Shutdown
Chang, Y., Huang, R., Ge, X., Huang, X., Hu, J., Duan, Y., Zou, Z., Liu, X., & Lehmann, M. F. (2020) · Geophysical Research Letters · doi:10.1029/2020gl088533 · Cited by 253
Zhang, W. S., Pan, J., Li, F., Zhu, M., Xu, M., Zhu, H., Yu, Y., & Su, G. (2021) · Analytical Chemistry · doi:10.1021/acs.analchem.1c00013 · Cited by 253
Metadata
- Authors
- Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Song, Z.-G., Hu, Y., Tao, Z.-W., Tian, J.-H., Pei, Y.-Y., Yuan, M.-L., Zhang, Y.-L., Dai, F.-H., Liu, Y., Wang, Q.-M., Zheng, J.-J., Xu, L., Holmes, E. C., & Zhang, Y.-Z.
- Affiliations
- Fudan University (CN)
- Wuhan Center for Disease Control and Prevention (CN)
- Chinese Center For Disease Control and Prevention (CN)
- Central Hospital of Wuhan (CN)
- The University of Sydney (AU)
- Corresponding author
- Zhang, Yu-Ling
- Venue
- Nature
- Published
- 2020-02-03
- Volume
- 579
- Issue
- 7798
- Pages
- 265-269
- ISSN
- 0028-0836 (ISSN-L)
- 1476-4687
- PMC
- PMC7094943
- OpenAlex
- W3003217347
- Cited by
- 11,688
- References
- 47
- Citations by year
- 2026: 223 · 2025: 481 · 2024: 839 · 2023: 1294 · 2022: 2184 · 2021: 3232 · 2020: 3416
- FWCI
- 333.80
- Type
- journal article
- Language
- en
- Update notices
- correction (2020-04-02)
- Open access
- hybrid
- doi.org
- Locations
- Nature (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (publishedVersion, cc-by)
- RePEc: Research Papers in Economics (submittedVersion)
- LA Referencia (Red Federada de Repositorios Institucionales de Publicaciones Científicas) (submittedVersion, cc-by)
- The Sydney eScholarship Repository (The University of Sydney) (submittedVersion)
- Funders
- National Natural Science Foundation of China (81861138003, 31930001)
- Australian Research Council (FL170100022)
- Topics
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Life Sciences › Agricultural and Biological Sciences › Animal Science and Zoology › Animal Virus Infections Studies
- Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Zoonotic diseases and public health
- Keywords
- SARS-CoV-2, novel coronavirus, SARS-like coronaviruses, Betacoronavirus, Sarbecovirus, SARS, animal-to-human transmission, Wuhan, phylogenetic analysis, viral genome, emerging infectious diseases
- MeSH terms
- Whole Genome Sequencing, Betacoronavirus, COVID-19, SARS-CoV-2, Adult, China, Humans, Lung, Male, Phylogeny, Pneumonia, Viral, Recombination, Genetic, RNA, Viral, Tomography, X-Ray Computed, Genome, Viral, Coronavirus Infections, Communicable Diseases, Emerging, Severe Acute Respiratory Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review